Recently, Stem Cell Therapeutics Corp. ("SCT") (TSX VENTURE:SSS) was honoured as one of Canada's Top 10 Life Sciences Companies by the Ottawa Life Sciences Council. Accompanying this honour was an opportunity for SCT to present to an audience of top-tier US venture capitalists and investment bankers at an exclusive Investment Forum hosted by the Canadian Consulate General. This week, Dr. Alan Moore, SCT's President and CEO, will present on Tuesday January 30th in Boston, MA then on Thursday February 1st in New York, NY.
